Uses of Smectaneo

Smectaneo medicine has the main active ingredient is Diosmectit with the content of 3g and other excipients in sufficient quantity. This is a medicine for the treatment of diseases of the gastrointestinal tract, specifically for the pain of inflammation of the esophagus, stomach and intestines. Read the article below to get more useful information about the use of this drug.

The main active ingredient Diosmectite in Smectaneo is a natural aluminum magnesium silicate. With a layer-by-layer dyscoid crystal structure with high viscosity and high adsorption capacity, it has specific effects as follows:
Protects the digestive mucosa by coating them with a uniform film. The main active ingredient Diosmectite has the ability to bind multiple covalently to glycoproteins of the intestinal mucosa, thus increasing the resistance of the mucus layer to agents that irritate the intestinal mucosa such as hydrochloric acid, bile acid salts and other stimulants. Adsorption of toxins, viruses, bacteria, fluids, gases, thus, reducing the signs and symptoms of diarrhea; inflammation of the esophagus, stomach and intestines. The local hemostatic effect should prevent bleeding or bleeding when the intestine is irritated. Smectaneo is used in the treatment of the following diseases:
Treatment of signs and symptoms of pain of inflammation of the esophagus, stomach and intestines. Treatment of acute or chronic diarrhea after rehydration and electrolytes are still persistent diarrhea. Supportive therapy with electrolyte replacement therapy in acute and chronic diarrhea, especially in children. However, patients with hypersensitivity or hypersensitivity to any of the ingredients of the drug and children with acute diarrhea with severe dehydration and electrolyte loss will not be prescribed the drug.

2.1. For children Dosage for children under 1 year old: 1 pack per day, divided 2-3 times. Dosage for children from 1 to 2 years old: 1 to 2 sachets per day, divided into 2 to 3 times. Dosage for children over 2 years old: take 2-3 sachets a day, divided into 2-3 times. Mix each sachet with about 50 ml of water, shake or stir well before each use. The water can be replaced with a liquid food such as broth or vegetable broth or mixed thoroughly with a semi-liquid food such as a vegetable puree. 2.2. For adults Adults use 1 pack each time, mix in half a cup of warm water, stir well and drink 3 times a day. Take Smectaneo after meals for people with esophagitis. Take away from meals with other indications. Particularly for the treatment of ulcerative colitis using rectal enema: 1 - 3 sachets each time mixed with 50-100 ml of warm water, then enema. Enema 1 to 3 times a day. In case of acute diarrhea, the daily therapeutic dose may be doubled at the beginning of treatment.

During the use of Smectaneo, users of the drug may experience undesirable effects such as digestive disorders, constipation or more severe constipation, very rarely.
This undesirable effect can be managed by continuing treatment by reducing the therapeutic dose or discontinuing the drug. You need to proactively inform the treating doctor about the unwanted effects encountered when using Smectaneo medicine.

The absorption properties of the active ingredient Diosmectite may alter the timing and/or absorption of other drugs. Therefore, if Smectaneo is used with other drugs, the time between doses should be extended.

When the user of Smectaneo has a fever, do not take the medicine for more than 2 days. Rehydration should be carried out if necessary by direct oral or intravenous infusion, depending on the age, physical condition of each person and the degree of dehydration caused by diarrhea. For people with esophagitis should take the medicine after meals. The active ingredient Diosmectite has no effect on the treatment of dehydration, so appropriate rehydration measures should always be taken when the body is dehydrated. The amount of water to be rehydrated and how to rehydrate it either by mouth or intravenously depends on the severity of the diarrhea, the age and medical condition of the individual. There are no data regarding the use of Diosmectite or Smectaneo in pregnant and lactating women. Effects on ability to drive and use machines: There is no research and clear experimental evidence yet.